Americhem completed the acquisition of Controlled Polymers from Blue Equity and Chrispa.

Americhem, a global masterbatch manufacturer, completed the acquisition of Controlled Polymers, a global manufacturer of customised compounds and masterbatch for the medical industry, amongst others, from private equity firm Blue Equity and investment company Chrispa. Financial terms were not disclosed. “We are delighted to join the Americhem family and specifically Americhem Engineered Compounds. Our companies’ customers will continue to experience the same dedicated quality and service as always, but with an expanded global reach and deeper breadth of product offerings,” Mogens Larsen, Controlled Polymers CEO.